Google
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
Biotech stock Avalo Therapeutics skyrocketed to a two-year high Wednesday on positive results for its skin disease treatment.
Continue Reading
Get personalized investment ideas from AI Coach, manage and analyze your own Portfolio & Watchlist, and receive dedicated support when you need account assistance.
Continue with FacebookUser not found.
Biotech stock Avalo Therapeutics skyrocketed to a two-year high Wednesday on positive results for its skin disease treatment.
Continue Reading
